Establishing Potosi Virus as a Human Pathogen

Objectives To establish Potosi virus, a mosquito-borne member of the family Peribunyaviridae , as a neuroinvasive human pathogen. Methods Case report. Results A 37-year-old woman with multiple sclerosis on long-term rituximab developed rapidly progressive dementia. Serial MRI demonstrated progressive generalized atrophy. CSF showed transient, minimal lymphocytic pleocytosis. Extensive infectious, autoimmune, and prion evaluations were unrevealing, but CSF metagenomic sequencing detected all 3 genome segments for Potosi virus. Postmortem examination revealed diffuse meningoencephalitis with T-cell–predominant leptomeningeal and perivascular inflammation. Molecular analyses confirmed multiple nucleotide sequences with >99+% concordance with a known Potosi strain, with widespread viral infection confirmed by immunohistochemistry demonstrating intracellular and extracellular viral antigen. Electron microscopy demonstrated particles of a size consistent with the Peribunyaviridae family. Metagenomic sequencing of RNA extracted from frozen brain tissue identified all 3 Potosi virus gene segments without other infectious entities. Findings were concordant across multiple laboratories and institutions. Discussion Potosi virus can cause fatal neuroinvasive disease in humans, as evidenced by convergent postmortem neuropathologic, molecular, and ultrastructural evidence. Chronic B-cell depletion may increase susceptibility to severe disease with arboviral infections, which may present without conventional CNS inflammatory markers. CSF metagenomic sequencing should be considered in immunocompromised patients with unexplained progressive neurologic decline.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2026-10-29
DOI
https://doi.org/10.1212/wnl.0000000000218683
Primary Topic
Viral Infections and Vectors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Establishing Potosi Virus as a Human Pathogen

Julian A. Villalba, Carlos M. Isada, Robert James Fox, Price Tipping et al.
Neurology
Viral Infections and Vectors
article

Establishing Potosi Virus as a Human Pathogen

Julian A. Villalba, Carlos M. Isada, Robert James Fox, Price Tipping, Gabrielle A. Yeaney, Bruce D. Trapp, Feroza Begum, Anthony M. Chomyk, Justin Abbatemarco, Stephen E. Jones, Aaron C. Brault, Amanda E. Calvert, Soowon Kang, Kunio Nakamura, Emily H. Davis, Yuebing Li, Julu Bhatnagar, Carolyn V. Gould, Liane Najm, Jae U Jung, Erin J. Staples, Yunyeong Ko
article en

Abstract

Objectives To establish Potosi virus, a mosquito-borne member of the family Peribunyaviridae , as a neuroinvasive human pathogen. Methods Case report. Results A 37-year-old woman with multiple sclerosis on long-term rituximab developed rapidly progressive dementia. Serial MRI demonstrated progressive generalized atrophy. CSF showed transient, minimal lymphocytic pleocytosis. Extensive infectious, autoimmune, and prion evaluations were unrevealing, but CSF metagenomic sequencing detected all 3 genome segments for Potosi virus. Postmortem examination revealed diffuse meningoencephalitis with T-cell–predominant leptomeningeal and perivascular inflammation. Molecular analyses confirmed multiple nucleotide sequences with >99+% concordance with a known Potosi strain, with widespread viral infection confirmed by immunohistochemistry demonstrating intracellular and extracellular viral antigen. Electron microscopy demonstrated particles of a size consistent with the Peribunyaviridae family. Metagenomic sequencing of RNA extracted from frozen brain tissue identified all 3 Potosi virus gene segments without other infectious entities. Findings were concordant across multiple laboratories and institutions. Discussion Potosi virus can cause fatal neuroinvasive disease in humans, as evidenced by convergent postmortem neuropathologic, molecular, and ultrastructural evidence. Chronic B-cell depletion may increase susceptibility to severe disease with arboviral infections, which may present without conventional CNS inflammatory markers. CSF metagenomic sequencing should be considered in immunocompromised patients with unexplained progressive neurologic decline.

NeurologyVol. 107(10)
Centers for Disease Control and Prevention (US), Cleveland Clinic (US), National Center for Emerging and Zoonotic Infectious Diseases (US), Cleveland Clinic Research (US)
Good health and well-being
Openalex Percentile: Top 12%
Viral Infections and Vectors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon